Haystack MRD™ by Quest Diagnostics is a tumor-informed, next-generation minimal residual disease (MRD) test that detects ultralow levels of circulating tumor DNA (ctDNA) to uncover residual disease after cancer treatment. Based on more than 20 years of clinical development and technology from pioneers in cancer genomics at Johns Hopkins University, Haystack MRD's purpose-built, high-precision science delivers novel insights that can help inform treatment decision-making.
View Top Employees from Haystack OncologyWebsite | http://www.haystackmrd.com |
Employees | 53 (44 on RocketReach) |
Founded | 2021 |
Address | 301 W 29th St Suite 2004U, Baltimore, Maryland 21211, US |
Industry | Biotechnology Research |
Looking for a particular Haystack Oncology employee's phone or email?
Dan Edelstein is the CEO of Haystack Oncology.
44 people are employed at Haystack Oncology.
Haystack Oncology is based in Baltimore, Maryland.